Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin

Dual and triple infections with hepatitis virus C (HCV), B (HBV) and D (HDV) frequently lead to severe liver damage. Hereby we describe a 38-year-old Caucasian male coinfected with HCV (genotype 3a), HBV [positive hepatitis B surface antigen (HbsAg) and antibody to hepatitis B core antigen; negative...

Full description

Bibliographic Details
Main Authors: Janine Hartl, Claudia Ott, Gabriele Kirchner, Bernd Salzberger, Reiner Wiest
Format: Article
Language:English
Published: MDPI AG 2012-07-01
Series:Clinics and Practice
Subjects:
HCV
HBV
HDV
triple-hepatitis
pegylated interferon
ribavirin.
Online Access:https://www.clinicsandpractice.org/index.php/cp/article/view/350

Internet

https://www.clinicsandpractice.org/index.php/cp/article/view/350

Similar Items